Understanding how lung blood vessels affect the immune system during lung injuries
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
This study is looking at how certain cells in the blood vessels of the lungs help control the immune response during serious lung injuries, like those from trauma or infections, to find new ways to treat conditions like Acute Respiratory Distress Syndrome (ARDS).
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10914668 on NIH RePORTER |
What this research studies
This research investigates the role of lung blood vessel cells in regulating the immune response during acute lung injuries, such as those caused by trauma or infections. By examining how these cells interact with immune cells, the study aims to uncover mechanisms that could lead to new targeted therapies for conditions like Acute Respiratory Distress Syndrome (ARDS). The researchers will utilize advanced techniques, including RNA sequencing, to analyze gene expression changes in lung endothelial cells. This approach will help identify potential therapeutic targets to improve lung function and patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing acute lung injuries or conditions like ARDS.
Not a fit: Patients with chronic lung diseases or those not currently experiencing acute lung injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance lung recovery and immune function in patients suffering from acute lung injuries.
How similar studies have performed: Previous research has shown promising results in understanding the immune functions of lung endothelial cells, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mehta, Dolly — University of Illinois at Chicago
- Study coordinator: Mehta, Dolly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.